Satiety effects of a physiological dose of cholecystokinin in humans
- PMID: 7883212
- PMCID: PMC1382399
- DOI: 10.1136/gut.36.2.176
Satiety effects of a physiological dose of cholecystokinin in humans
Abstract
Cholecystokinin 33 (CCK) was infused intravenously to eight healthy obese women and 10 healthy lean women of the same age, in doses that elicited plasma cholecystokinin concentrations in the physiological range. The effect of these infusions after a standardised banana 'shake' (preload) on food intake and satiety signals was compared with the effect of saline infusions in the same subjects. For the whole group food intake (mean (SEM)) (282 (29 g)) was significantly less during CCK than during saline (346 (31) g, p < 0.05). Hunger feelings tended to be less during CCK infusions. Examination of the separate subgroups showed no differences between lean and obese subjects in the satiety effects of CCK. In conclusion, under the conditions of this study, CCK significantly decreases food intake in humans, and this effect is similar for lean and obese subjects.
Similar articles
-
Effects of a physiological dose of cholecystokinin on food intake and postprandial satiation in man.Regul Pept. 1993 Jan 22;43(1-2):83-9. doi: 10.1016/0167-0115(93)90410-a. Regul Pept. 1993. PMID: 8426911
-
Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.Gut. 1994 Apr;35(4):501-5. doi: 10.1136/gut.35.4.501. Gut. 1994. PMID: 8174988 Free PMC article. Clinical Trial.
-
Significant satiety effect of bombesin in lean but not in obese subjects.Int J Obes Relat Metab Disord. 1994 Aug;18(8):579-83. Int J Obes Relat Metab Disord. 1994. PMID: 7951480 Clinical Trial.
-
The satiety effect of cholecystokinin: a progress report.Peptides. 1981;2 Suppl 2:57-9. doi: 10.1016/0196-9781(81)90011-5. Peptides. 1981. PMID: 6283497 Review.
-
Cholecystokinin and satiety: current perspectives.Nutrition. 2000 Oct;16(10):858-65. doi: 10.1016/s0899-9007(00)00419-6. Nutrition. 2000. PMID: 11054590 Review.
Cited by
-
Obesity treatment: novel peripheral targets.Br J Clin Pharmacol. 2009 Dec;68(6):830-43. doi: 10.1111/j.1365-2125.2009.03522.x. Br J Clin Pharmacol. 2009. PMID: 20002077 Free PMC article. Review.
-
Cholecystokinin tunes firing of an electrically distinct subset of arcuate nucleus neurons by activating A-Type potassium channels.J Neurosci. 2002 Aug 1;22(15):6380-7. doi: 10.1523/JNEUROSCI.22-15-06380.2002. J Neurosci. 2002. PMID: 12151516 Free PMC article.
-
Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity.Front Physiol. 2019 Jun 11;10:704. doi: 10.3389/fphys.2019.00704. eCollection 2019. Front Physiol. 2019. PMID: 31281260 Free PMC article.
-
Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.Physiol Rev. 2017 Jan;97(1):411-463. doi: 10.1152/physrev.00031.2014. Physiol Rev. 2017. PMID: 28003328 Free PMC article. Review.
-
The gut and food intake: an update for surgeons.J Gastrointest Surg. 2001 Sep-Oct;5(5):556-67. doi: 10.1016/s1091-255x(01)80095-0. J Gastrointest Surg. 2001. PMID: 11986008 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources